行业研究报告

2024全球生物医药与医疗技术交易深度洞察(英)

2025-06生物技术29

An in-depth analysis of 2024’s global deal-making trends. This report unpacks the year’s biggest moves, top therapeutic areas, and standout transactions as tracked by Biomedtracker.

报告摘要

An in-depth analysis of 2024’s global deal-making trends. This report unpacks the year’s biggest moves, top therapeutic areas, and standout transactions as tracked by Biomedtracker.

核心要点

  1. 2024 Deal-making
  2. 2024 deal volume showed a slight increase
  3. 2024 also ramped up in both dollar value and
  4. 2024 Deal-making Roundup

报告信息

文件全名
2024全球生物医药与医疗技术交易深度洞察(英)-29页.pdf
适合读者
战略规划行业研究员
核心数据
  1. an increase of 4% over 2023’s average PDV.
  2. 13% rise in the number of transactions as well as
  3. a 19% increase in deal value over 2023’s totals.
  4. was also up by 6% compared to 2023.
  5. from 57 deals, a 32% increase in deal value, yet
核心议题
生物医药

常见问题

《2024全球生物医药与医疗技术交易深度洞察(英)》主要包含哪些内容?

An in-depth analysis of 2024’s global deal-making trends. This report unpacks the year’s biggest moves, top therapeutic areas, and standout transactions as tracked by Biomedtracker.核心数据:an increase of 4% over 2023’s average PDV.;13% rise in the number of transactions as well as;a 19% increase in deal value over 2023’s totals.。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 29。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合战略规划、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了生物医药等议题。

继续阅读

同分类报告

查看全部
📱 登录